Novartis raises drug sales forecast, plans new stock buybacks
Bio Pharma Dive
JULY 18, 2023
The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.
Drugs Pharma Companies Sales 
BMS: Delayed new drug to avoid paying billions?
World of DTC Marketing
FEBRUARY 25, 2022
billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec.
Drugs 
216
216 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delhi HC grants 10 days’ time to Govt to file counter affidavit on petitions against ban of 14 FDCs
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 11, 2023
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
Pharma Companies 186
186 
Half a million-dollar bonus for cancer drug price increase
World of DTC Marketing
OCTOBER 1, 2020
WHAT NOW: The idea that most pharma companies are here to serve patients is a canard. Pharma CEO’s serve themselves with big salaries tied to drug prices and keeping drugs from coming off patent. “Did the drug get substantially more effective in that time? Did cancer patients need fewer pills?”
Drugs 181
181 
Biogen continues to sink
World of DTC Marketing
FEBRUARY 7, 2022
” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). At 99% of pharma companies, that's a huge no-no. ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales).
Pharma Companies 253
253 
Pharma: The time is now for digital marketing
World of DTC Marketing
JANUARY 14, 2021
Pharma Executive says “just as HCPs are being forced to embrace telemedicine, pharma companies are also being forced to embrace virtual interactions with HCPs. COVID-19 has stopped almost all in-person detailing by sales reps” . Will digital replace the sales force?
Marketing 180
180 
The current pharma business model is unsustainable
World of DTC Marketing
SEPTEMBER 7, 2022
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. They relied so much on a new drug that they tried to market a product with bad science behind it.
Pharma Companies 210
210 
The benefits of being a family-run pharma company
pharmaphorum
SEPTEMBER 22, 2021
When the pandemic emerged, there was an urgent need for quick decisions and swift adaptability while continuing to ensure the safety of employees and limited disruption of the manufacturing and supply chain for much needed and potentially lifesaving drugs for patients.
Pharma Companies 111
111 
Ipsen plans sale of consumer health business for €350m
pharmaphorum
FEBRUARY 11, 2022
Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. The post Ipsen plans sale of consumer health business for €350m appeared first on.
Sales 103
103 
To insource or outsource drug commercialisation? Flexibility is the answer
Pharmaceutical Technology
SEPTEMBER 2, 2022
The rate of drug approvals could be on the rise. In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse.
Drugs 130
130 
Product launch metrics are changing in pharma
World of DTC Marketing
APRIL 5, 2022
What is the definition of a successful pharma product launch? Usually, it’s reaching a certain sales level within a specified time, but that metric is not relevant anymore. Pharma companies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics.
Production 196
196 
The fairytale of DTC TV ads
World of DTC Marketing
JULY 21, 2022
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. They’re surprised that physicians don’t always give patients the drug they ask for, and they are amazed that many, who are considering the drug, are turned away by what they read online.
Marketing 266
266 
Pharma websites need disruption
World of DTC Marketing
DECEMBER 1, 2020
Walk into any corporate pharma HQ, and you’re likely to see a mission statement that’s pure b t about how patients come first. We all know that Wall Street and sales come well before patients. Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. Want proof?
Lilly has a new blockbuster
World of DTC Marketing
MAY 16, 2022
Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. The drug led to impressive blood sugar and body weight drops in clinical trials. Will patients, who are obese and don’t have Type 2 diabetes, ask for the drug for weight loss, and will patients understand the risks? A matter of trust?
Drugs 218
218 
California’s low-cost insulin plans receive $100m manufacturing boost
Pharmaceutical Technology
JULY 15, 2022
CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk. In-house manufacturing the norm.
Insulin 328
328 
Pharma is in acquisition mode but small biotechs hurting for money
World of DTC Marketing
JANUARY 10, 2022
Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3
Production 213
213 
STAT+: Pharmalittle: Study of Covid-19 therapy revives debate over FDA clearance; pharma companies are ready to make deals
STAT News
FEBRUARY 9, 2023
Executives at Pfizer, Merck, and Novartis are looking for promising drugs to add to their pipelines and replenish sales as top-selling products lose patent protection in the coming years. The acquisitions could help the companies add new sales to aging line-ups and suggest this year could be a busy one for industry dealmaking.
Takeda agrees $2.3bn sale of Japanese consumer health unit
pharmaphorum
AUGUST 24, 2020
Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion yen ($567 million) in fiscal 2019.
Sales 80
80 
Bayer sells testosterone drug rights to Grünenthal for €500m
pharmaphorum
JULY 14, 2022
Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year. The post Bayer sells testosterone drug rights to Grünenthal for €500m appeared first on.
Drugs 97
97 
Pharma’s digital transformation journey and the role of customer reference data
pharmaphorum
OCTOBER 7, 2020
Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. One of the noticeable effects of this has been a massive uptake of remote working across the industry, which has accentuated difficulties in conducting remote sales engagements due to poor customer data quality.
Pharma Companies 144
144 
Teva faces EU antitrust probe over MS drug Copaxone
pharmaphorum
MARCH 5, 2021
The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone. In the end it wasn’t enough and sales last year were $213 million, a fraction of the $4.3
Drugs 98
98 
Passing the trash
World of DTC Marketing
MARCH 24, 2022
I’ve seen some new energy and thinking taking root in some big pharma companies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharma company in Cambridge.
Pharma Companies 213
213 
Medscape on shift to digital
World of DTC Marketing
AUGUST 23, 2020
Digital channels play a far greater role in communication between pharma companies and healthcare professionals than before the pandemic. . Drug companies need to develop a model in which there is continuous improvement in online interactions. Pharma is not about to abandon sales people anytime soon.
Pharma Companies 213
213 
DTC as part of an integrated strategy
World of DTC Marketing
AUGUST 29, 2022
A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. The research showed that patients wanted to understand how the drug works and the potential side effects.
Branding 203
203 
The downside of VC funding for biotech
World of DTC Marketing
JANUARY 24, 2022
Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8
Life Science 225
225 
An increasing impact of BCMA-targeting biologics in multiple myeloma
Pharmaceutical Technology
SEPTEMBER 2, 2022
This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie. billion global sales expected by 2028, followed by Tecvayli with $2.6bn, which would mark a huge win for J&J in the MM space.
Antibody 147
147 
Idorsia is first to EU market with orexin insomnia drug
pharmaphorum
MAY 3, 2022
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. It was due to be launched in the US yesterday.
Marketing 97
97 
The four biggest challenges facing DTC marketers
World of DTC Marketing
APRIL 6, 2022
Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. ” Too many DTC marketing people have come from the sales force and have a sales mentality at a time when people don’t want the hard sales pitch.
Marketing 196
196 
In the News: October Regulatory and Development Updates
Camargo
NOVEMBER 11, 2020
When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.
Development 242
242 
Social media and DTC
World of DTC Marketing
NOVEMBER 11, 2020
If a new drug, for example, has a unique message, I would definitely recommend social media, but if you’re saying the same thing you say in TV spots, you’re probably wasting your time. Content that informs, educates and talks to online health seekers is more important than sales talk.
Marketing 195
195 
Insulin prices demonstrate pharma’s greed
World of DTC Marketing
DECEMBER 14, 2021
PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering. Millions of Americans use insulin for diabetes, and the drug can cost as much as $1,000 a month. It’s time to admit that pharma is out of control. The post Insulin prices demonstrate pharma’s greed.
Insulin 184
184 
Redx shares soar after IPF drug licence deal with AstraZeneca
pharmaphorum
AUGUST 4, 2020
Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015.
Drugs 109
109 
Top 10 Pharma and Biotech M&As in the Past Decade
XTalks
JANUARY 20, 2025
Key benefits included the addition of Celgenes blockbuster drug Revlimid (lenalidomide), a cornerstone of its oncology portfolio, and access to innovative CAR-T therapies such as Abecma (idecabtagene vicleucel). While the deal required regulatory divestitures, including the sale of Otezla (apremilast) to Amgen for $13.4
Marketing 104
104 
Can vouchers incentivise antimicrobial drug discovery in Europe?
Pharmaceutical Technology
JUNE 22, 2023
The European Commission’s (EC) plan to test a novel scheme to incentivise antimicrobial drug development companies remains beset by questions amidst the bloc’s drive to tackle the growing threat of antimicrobial resistance (AMR). The EU previously focused on AMR through the One Health Action Plan, which was released in 2017.
Drugs 130
130 
Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album
pharmaphorum
JULY 28, 2021
The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by ‘pharma bro’ Martin Shkreli, with the proceeds enough to wipe out his $7.4 He was also convicted of manipulating the price and trading volume of stock in Retrophin, another pharma company he founded in 2011. Via wikimedia.org.
Sales 105
105 
What are the Vital Advantages Offered by PCD Pharma Companies?
Fossil Remedies
DECEMBER 29, 2022
There are many types of pharma businesses and one can choose any of them. Launching a pcd pharma company, for example, can be a way of reaping the benefit of pharma boom. If you are running a small business in this niche, then it is time for you to invest in any of the good pharma companies. Conclusion.
Gilead pays $97m to resolve US illegal kickback claims
pharmaphorum
SEPTEMBER 24, 2020
Gilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a charitable foundation as a conduit to fund co-payments of thousands of Medicare patients taking its pulmonary arterial hypertension drug, Letairis. Gilead is not the only pharma company alleged to have used kickbacks to cover the cost of copays.
Pharma companies in Baddi
Creogenic Pharma
APRIL 15, 2023
India is a major player in the global pharmaceutical industry, accounting for almost 20% of the export volume of generic drugs worldwide. We understand the challenges and complexities of meeting the standards set by drug authorities and take them into consideration in all our operations.
Shareholders versus patients: Who is more important?
World of DTC Marketing
JUNE 22, 2021
Milton Friedman A newly approved drug to treat Alzheimer’s disease is expected to become a multibillion-dollar expense for Medicare. By one projection, spending on the drug for Medicare patients could end up being higher than the budgets for the Environmental Protection Agency or NASA. (New Milton Friedman.
Drugs 156
156 
Find your inner data and take precision marketing to the next level
pharmaphorum
MAY 24, 2022
It powers drug discovery, clinical trials, and operational performance. These challenges and efficiencies need to be met head-on as companies cannot afford to allow precious customer data, with influence across marketing, sales, and service, to lay unseen gathering cobwebs. Data is the powerhouse of the pharmaceutical sector.
Marketing 111
111 
Teva shares slide as it faces illegal kickback charges from US government
pharmaphorum
AUGUST 20, 2020
Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer). The allegation is that Teva’s subsidiaries Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.
Generic Drugs 115
115 
UK launches its ‘Netflix-style’ payment model for antibiotics
pharmaphorum
APRIL 12, 2022
Pfizer and Shionogi submitted the drugs for consideration in the scheme when it was first announced in 2019. While the UK on its own cannot reverse this trend, the hope is that if other countries around the world develop a similar model, pharma companies will be incentivised to develop new antimicrobials.
Pharma Companies 119
119 
Amgen splashes out on ChemoCentryx and its blockbuster hopeful
pharmaphorum
AUGUST 4, 2022
billion bid to buy out the company. The $52-per-share offer would give Amgen a drug that some analysts have described as a pipeline in a pill with $1 billion-plus sales potential, and is a sizeable premium on ChemoCentryx’ pre-deal announcement share price of just over $24.
Sales 98
98 
Jazz Pharma Announces $100 Million “Green” Manufacturing Plant for Cannabis-Based Medicines
XTalks
MARCH 29, 2022
According to a press release from Jazz Pharma, the plant has a planned opening date in 2024 and will welcome 100 new employees. The 60,000-square-foot facility was specially designed to support the company’s two regulatory-approved cannabis-based medicines and offer capacity for future drugs currently under development.
Medicine 111
111 
Let's personalize your content